Navigation Links
New book describes career opportunities in clinical research and how to qualify for them
Date:7/27/2010

COLD SPRING HARBOR, N.Y. (July 27, 2010) -- For those with an aptitude in science and an interest in working with medical discovery teams, careers at drug, medical device, and contract research organization (CRO) companies can be fulfilling. A new book from Cold Spring Harbor Laboratory Press, Career Opportunities in Clinical Drug Research, introduces readers to entry-level clinical job opportunities and explains how to qualify for them.

"[T]his book will pull back the curtain on rewarding and lucrative career opportunities that are rarely mentioned in academic degree programs," writes the author, Rebecca J. Anderson, in the book's preface. For more than 25 years, Anderson held a variety of research and development roles in pharmaceutical, biotechnology, medical device, and CRO companies. As a hiring manager in all of these organizations, she has reviewed and screened thousands of applicants for clinical research positions.

Anderson says that talented and interested applicants for jobs in clinical research often fall short because they lack clinical experience. "[U]ndergraduate and graduate students can acquire, in a number of ways, clinical experience that we will accept, and it is not difficult to obtain," she writes. Career Opportunities in Clinical Drug Research places a particular emphasis on how to gain this clinical experience.

The book begins with a brief overview of research and development in the pharmaceutical industry and explains how a typical clinical study is conducted. Each of the next eight chapters then covers one of the clinical specialties involved in conducting pharmaceutical clinical trials: for example, clinical research associate, clinical data manager, biostatistician, and clinical drug safety specialist. The chapters are written as personalized narratives, allowing the reader to follow the daily work of a clinical specialist as he or she supports a clinical study and interacts wi
'/>"/>

Contact: Ingrid Benirschke
benirsch@cshl.edu
619-275-6021
Cold Spring Harbor Laboratory
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Grinding mouth, wrinkle eye: Penn graduate student describes new species of plant-eating dinosaur
2. LSUHSC research describes function of key protein in cancer spread
3. 21 of Americas top early-career scientists named 2010 Pew Scholars in the biomedical sciences
4. Rensselaer Polytechnic Institute professor Patrick Underhill receives NSF CAREER award
5. K-State scientist to receive $1 million CAREER award
6. UDs Zhuang wins NSF Early Career Award for research on how cells bypass damaged DNA
7. Cancer therapy using unique imaging, delivery system focus of NSF CAREER Award
8. FSU biologist wins $1M Early Career Award from National Science Foundation
9. US women and minority scientists discouraged from pursuing STEM careers, national survey shows
10. NJIT electrical engineer Yanchao Zhang receives NSF CAREER Award
11. Carnegie Mellons John Kitchin receives early career award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New book describes career opportunities in clinical research and how to qualify for them
(Date:12/19/2014)... Dec. 18, 2014   LaunchKey , the first ... post-password and Internet of Things era, today announced the ... venture round was led by Metamorphic Ventures with participation ... Partners, VegasTechFund, and others.  LaunchKey has raised $4 million ... expand its team and bring LaunchKey to market in ...
(Date:12/17/2014)... DUBLIN , Dec. 16, 2014 Research ... announced the addition of the "Global Chemical ... http://photos.prnewswire.com/prnh/20130307/600769 ... is the increasing demand for medical sensors in ... patient data for quick and correct diagnosis during ...
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays ... a while. Hypertension – the medical term for high blood ... early 1800s, and the inflatable cuff that,s used in measuring ... however, mean there,s nothing new about hypertension, its triggers and ... beliefs about the condition and the best ways to treat ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... our way out of ageing," says Nancy Ross, a McGill geography ... maybe some hearing loss, maybe lose some mobility ageing is ... lead author of a new study about how socio-economic and educational ... a lifetime. "My research looks at how poverty ...
... type of gorilla will receive a helping hand from Newman,s ... $150,000 grant to help save the Grauer,s gorilla in the ... The grant will help equip and support park rangers (or ... National Park, a World Heritage site that is now threatened ...
... This press release is available in German . ... diseases: the minute soot particles from the exhaust gas of ... In order to nevertheless keep the harmful effects to one,s ... for diesel soot have been lowered drastically step by step, ...
Cached Biology News:Lifelong gap in health between rich and poor set by age 20 2Wildlife Conservation Society receives $150,000 grant from Newman's Own Foundation to save gorillas 2Pan-European research project for clean air 2Pan-European research project for clean air 3
(Date:12/19/2014)... MA (PRWEB) December 18, 2014 iLab ... announced the appointment of Siri Bryant as the new ... new Director of Core Implementations. These two new leadership ... outstanding customer service by ensuring that iLab continues to ... “In the last four years, iLab has been deployed ...
(Date:12/19/2014)... BURLINGTON, Mass. , Dec. 18, 2014  Decision ... dental biomaterial market will grow moderately through ... implant procedures and growing awareness of dental biomaterials all ... underdeveloped markets such as China ... incomes will bring dental procedures within reach for a ...
(Date:12/17/2014)... (PRWEB) December 16, 2014 The ... since 2013, which is why IBISWorld updated its original ... continues to benefit from an intensified focus on environmental ... for new emission standards for power plants and a ... According to IBISWorld Industry Analyst Sarah Kahn, “a range ...
(Date:12/17/2014)... N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today announced ... (referred to as Somatuline®) was approved by the ... treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult ... advanced or metastatic disease to improve progression-free survival ...
Breaking Biology Technology:iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8
... Now in ... leaders from around the globe to discuss pain management, preclinical and clinical development of new ... Minneapolis, MN ... Summit , set to take place on October 4th-5th, 2010 in Philadelphia, has been announced., ...
... CAMBRIDGE, England , May 25, 2010 Executives ... announced today,an extension of the agreement under which O2h provides multi-FTE -synthetic,chemistry ... , , ... Head of Chemistry said, "We are happy to have signed,this new contract ...
... EXTON, Pa. , May 25 Fibrocell Science, ... the development of autologous cell therapies for aesthetic, medical and ... with Irish Voice newspaper and ... and Chief Financial Officer Declan Daly as a ...
Cached Biology Technology:Scientific and Business Leaders to Discuss Challenges Facing Developers of Pain Therapeutics at Arrowhead's 4th Annual Pain Therapeutics Summit 2Heptares Therapeutics Extends Multi-FTE Chemistry Collaboration With Oxygen Healthcare (O2h) 2Heptares Therapeutics Extends Multi-FTE Chemistry Collaboration With Oxygen Healthcare (O2h) 3The Irish Government and the Irish Voice Recognize Fibrocell Science, Inc.'s Declan Daly as 'Irish Life Science 50' Member 2
Immunogen: Synthetic peptide: N(171) H G F L S A D Q QL I K(183) Storage: -20 C, Avoid Freeze/Thaw Cycles...
The pCDF Expression System 1 plus Competent Cells contains 10 µg of pET-45b(+) DNA. pET-45b carries an N-terminal His•Tag ® coding sequence that is cleavable with enterokinase as well...
HIV-1 TAT (vN-21)...
Request Info...
Biology Products: